G protein-coupled receptors (GPCRs) are integral membrane proteins with seven membrane-spanning helices. Upon binding to a ligand – which can range from small molecules like cyclic AMP to ...

We recently compiled a list of the 12 NASDAQ Stocks with Biggest Upside Potential According to Analysts. In this article, we ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic ...

Septerna, Inc. ( (SEPN) ) has released its Q3 earnings. Here is a breakdown of the information Septerna, Inc. presented to ...

PTH1R is a G protein coupled-receptor (GPCR), part of a family of receptors that regulate a wide range of physiological processes. The role of these receptors in both health and disease is known ...

Begin your TipRanks Premium journey today. Septerna, Inc. (SEPN) Company Description: Septerna is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral ...

Trading for “SEPN” began on Friday. Interest in Septerna, which came out of stealth in January 2022, has been sparked by its development of G protein-coupled receptors (GPCRs). Using a ...

Over the years, chemical biology methods have made an important contribution to the study of integral membrane proteins. A ...

Tectonic is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (“GPCRs”). Leveraging its ...

Nxera Pharma (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio company ...